If you need help accessing our website, call 855-698-9991
Skip to main content
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Carol M. Lee, MD

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
  • Specialties: Retinal Ophthalmology, Ophthalmology
  • Treats: Adults
  • Languages: English, Korean
  • Phone: 212-684-2424
View Locations

Conditions and Treatments

Conditions
  • diabetic retinopathy
  • uveitis
Treatments
  • laser surgery
  • retinal surgery
  • vitrectomy

Board Certifications
  • American Board of Ophthalmology - Ophthalmology, 1991
Education and Training
  • Fellowship, Washington University Medical Center, Vitreoretinal Surgery, 1991
  • Residency, NYU Medical Center, Ophthalmology, 1989
  • Fellowship, University of Illinois Hospital and Clinics, Retina, 1986
  • MD from SUNY-Downstate, 1984

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Empire Blue Cross Blue Shield
     
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Oxford
     
    • Oxford Freedom
  • UHC
     
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Carol M. Lee, MD does not accept insurance.

Locations and Appointments

Carol M. Lee, M.D.

161 Madison Ave, Ste 5NE, New York, NY 10016

Phone

212-684-2424

Fax

212-448-0116

  • A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects with Non-Small Cell Lung Cancer

    Learn More
  • A DOSE-ESCALATION AND EXPANSION STUDY OF THE SAFETY AND PHARMACOKINETICS OF XB002 AS SINGLE-AGENT AND COMBINATION THERAPY IN SUBJECTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC SOLID TUMORS

    Learn More
  • An open label Phase I dose escalation trial with dose confirmation and expansion of BI 1810631 as monotherapy in patients with advanced or metastatic solid tumors with HER2 aberrations

    Learn More
View All Research Studies (18)

Read All Publications (23)